S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
Critical asset just had biggest fall on record (Ad)
Sports analytics may be outnumbered when it comes to artificial intelligence
In Senegal's capital, Nicaragua is a hot ticket among travel agents as migrants try to reach US
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Norway's hospitalized king gets a pacemaker in Malaysia after falling ill during vacation
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
Critical asset just had biggest fall on record (Ad)
What to watch for as China's major political meeting of the year gets underway
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
Critical asset just had biggest fall on record (Ad)
Sports analytics may be outnumbered when it comes to artificial intelligence
In Senegal's capital, Nicaragua is a hot ticket among travel agents as migrants try to reach US
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Norway's hospitalized king gets a pacemaker in Malaysia after falling ill during vacation
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
Critical asset just had biggest fall on record (Ad)
What to watch for as China's major political meeting of the year gets underway
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
Critical asset just had biggest fall on record (Ad)
Sports analytics may be outnumbered when it comes to artificial intelligence
In Senegal's capital, Nicaragua is a hot ticket among travel agents as migrants try to reach US
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Norway's hospitalized king gets a pacemaker in Malaysia after falling ill during vacation
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
Critical asset just had biggest fall on record (Ad)
What to watch for as China's major political meeting of the year gets underway
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
Critical asset just had biggest fall on record (Ad)
Sports analytics may be outnumbered when it comes to artificial intelligence
In Senegal's capital, Nicaragua is a hot ticket among travel agents as migrants try to reach US
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Norway's hospitalized king gets a pacemaker in Malaysia after falling ill during vacation
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
Critical asset just had biggest fall on record (Ad)
What to watch for as China's major political meeting of the year gets underway
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
NYSE:SNN

Smith & Nephew (SNN) Stock Price, News & Analysis

$26.42
-0.09 (-0.34%)
(As of 03/1/2024 ET)
Today's Range
$26.15
$26.58
50-Day Range
$26.42
$28.88
52-Week Range
$21.52
$33.08
Volume
945,589 shs
Average Volume
848,300 shs
Market Capitalization
$11.55 billion
P/E Ratio
N/A
Dividend Yield
2.12%
Price Target
N/A

Smith & Nephew MarketRank™ Stock Analysis

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
0.47% of Float Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
0.90mentions of Smith & Nephew in the last 14 days
Based on 9 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
18.68%
From $1.82 to $2.16 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.90 out of 5 stars

Medical Sector

670th out of 950 stocks

Surgical Appliances & Supplies Industry

16th out of 18 stocks


SNN stock logo

About Smith & Nephew Stock (NYSE:SNN)

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. The company operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures. It also provides sports medicine joint repair products, including instruments, technologies, and implants to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg wounds, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, as well as regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It primarily serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.

SNN Stock Price History

SNN Stock News Headlines

This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
Smith & Nephew reports Q4 results
Smith & Nephew price target lowered by 50 GBp at Berenberg
Critical asset just had biggest fall on record
What many consider America's critical financial asset suffers biggest fall on record. Expert says: "it's very bad for millions, protect yourself now."
Smith & Nephew 3Q Rev $1.357B
Smith & Nephew plc - ADR
Boeing, CyberArk Lead 5 Stocks Near Buy Points
See More Headlines
Receive SNN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Smith & Nephew and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/17/2014
Today
3/02/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical appliances & supplies
Sub-Industry
N/A
Employees
19,012
Year Founded
1856

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$5.55 billion
Cash Flow
$3.25 per share
Book Value
$11.93 per share

Miscellaneous

Free Float
432,787,000
Market Cap
$11.55 billion
Optionable
Optionable
Beta
0.74

Social Links

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Key Executives

  • Dr. Deepak S. Nath Ph.D. (Age 52)
    CEO & Director
    Comp: $5.96M
  • Ms. Anne-Francoise Nesmes (Age 53)
    CFO & Executive Director
    Comp: $1.35M
  • Mr. Paul Connolly (Age 56)
    President of Global Operations
  • Mr. Andrew Swift
    Vice President of Investor Relations
  • Ms. Helen Barraclough (Age 44)
    Group General Counsel & Company Secretary
  • Ms. Alison Parkes (Age 51)
    Chief Compliance Officer & Compliance APAC
  • Mr. Joe Metzger
    Senior Vice President of Marketing Services & Communications
  • Mr. Philip G. Cowdy (Age 57)
    Chief Corporate Development & Corporate Affairs Officer
  • Ms. Elga Lohler (Age 56)
    Chief Human Resources Officer
  • Mr. Bradley Cannon (Age 56)
    President of Global Orthopaedics














SNN Stock Analysis - Frequently Asked Questions

Should I buy or sell Smith & Nephew stock right now?

7 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Smith & Nephew in the last twelve months. There are currently 3 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" SNN shares.
View SNN analyst ratings
or view top-rated stocks.

How have SNN shares performed in 2024?

Smith & Nephew's stock was trading at $27.28 at the beginning of the year. Since then, SNN stock has decreased by 3.2% and is now trading at $26.42.
View the best growth stocks for 2024 here
.

Are investors shorting Smith & Nephew?

Smith & Nephew saw a increase in short interest in the month of February. As of February 15th, there was short interest totaling 2,020,000 shares, an increase of 41.3% from the January 31st total of 1,430,000 shares. Based on an average daily trading volume, of 919,200 shares, the short-interest ratio is presently 2.2 days. Currently, 0.5% of the shares of the stock are sold short.
View Smith & Nephew's Short Interest
.

How were Smith & Nephew's earnings last quarter?

Smith & Nephew plc (NYSE:SNN) issued its earnings results on Monday, November, 17th. The medical equipment provider reported $0.98 EPS for the quarter, topping the consensus estimate of $0.39 by $0.59.

How often does Smith & Nephew pay dividends? What is the dividend yield for Smith & Nephew?

Smith & Nephew announced a semi-annual dividend on Thursday, August 3rd. Shareholders of record on Friday, October 6th will be paid a dividend of $0.462 per share on Wednesday, November 1st. This represents a dividend yield of 2.6%. The ex-dividend date is Thursday, October 5th.
Read our dividend analysis for SNN
.

Is Smith & Nephew a good dividend stock?

Smith & Nephew (NYSE:SNN) pays an annual dividend of $0.56 per share and currently has a dividend yield of 2.10%.
Read our dividend analysis for SNN.

What other stocks do shareholders of Smith & Nephew own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Smith & Nephew investors own include Smith & Nephew (SN), RPM International (RPM), Gilead Sciences (GILD), AbbVie (ABBV), Alibaba Group (BABA), Johnson & Johnson (JNJ), Pfizer (PFE), Abbott Laboratories (ABT), Alexion Pharmaceuticals (ALXN) and Amgen (AMGN).

Who are Smith & Nephew's major shareholders?

Smith & Nephew's stock is owned by many different institutional and retail investors. Top institutional shareholders include Fiduciary Management Inc. WI (1.11%), Scharf Investments LLC (0.68%), Goldman Sachs Group Inc. (0.31%), Goldman Sachs Group Inc. (0.31%), Brandes Investment Partners LP (0.25%) and Wells Fargo & Company MN (0.23%).

How do I buy shares of Smith & Nephew?

Shares of SNN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:SNN) was last updated on 3/2/2024 by MarketBeat.com Staff